TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CellSource Co., Ltd. ( (JP:4880) ) just unveiled an announcement.
CellSource Co., Ltd. announced a change in its representative director, with Dr. Masayuki Yamakawa assuming the role of Representative Chairman of the Board. This change aims to capitalize on Dr. Yamakawa’s medical expertise to enhance the company’s strategic management and realize its ‘CellSource Vision’ for sustainable growth and increased corporate value.
More about CellSource Co., Ltd.
CellSource Co., Ltd. operates in the medical industry, focusing on regenerative medicine and related healthcare services. The company is known for its innovative approaches in medical treatments, leveraging expertise in cell-based therapies.
YTD Price Performance: -2.16%
Average Trading Volume: 100,191
Technical Sentiment Consensus Rating: Buy
Current Market Cap: Yen15.97B
For a thorough assessment of 4880 stock, go to TipRanks’ Stock Analysis page.